Clin2
NCT06554496Possibly a fitRecruiting

Xanthine Oxidoreductase Levels in New Sleep Apnea Patients

Obstructive Sleep Apnea

Part of Brain & nervous system, Lungs & breathing clinical trials.

This study measures a substance called XOR in the blood of people who have just been diagnosed with obstructive sleep apnea but haven't started treatment yet. It aims to see if XOR levels are linked to sleep apnea.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
80 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are between 18 and 80 years old.
  • You have just been diagnosed with obstructive sleep apnea (based on a sleep test showing at least 5 breathing pauses per hour).
  • You have never had surgery or used a CPAP machine for sleep apnea.
  • You do not have serious conditions like a recent stroke, active cancer, severe lung disease, or uncontrolled diabetes.
  • You are not pregnant or too frail to take part.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07723144Recruiting
Identifying sleep apnea biomarkers

This study compares blood samples from people with moderate-to-severe sleep apnea and those without sleep apnea to find markers that could help diagnose or treat the condition. Half of those with sleep apnea will start CPAP therapy right away, while others wait before starting.

Bialystok, Podlaskie Voivodeship
NCT04675268Recruiting
Testing nighttime oxygen patterns in suspected sleep apnea

This study looks at how oxygen levels change during the night in people who might have obstructive sleep apnea (OSA). It may help doctors better understand breathing problems during sleep and improve how OSA is evaluated.

Leuven
NCT06687655Not yet recruiting· Phase 1/Phase 2
Exogenous ketones for sleep apnea study

This trial tests whether taking a ketone supplement can improve sleep apnea in people who use CPAP. You may qualify if you have moderate to severe sleep apnea and use your CPAP regularly.

Baltimore, Maryland
NCT06189755Recruiting
MicroRNA markers for sleep apnea

This trial is studying tiny molecules in the blood (called microRNAs) to see if they can help diagnose or monitor obstructive sleep apnea. It compares people with moderate to severe sleep apnea who are starting PAP therapy with people who do not have sleep apnea.

Columbus, Ohio
NCT03736382Recruiting
Study how mild low-oxygen affects sleep apnea and blood pressure

This trial studies whether mild, controlled low oxygen during sleep can change sleep apnea symptoms and related blood pressure issues. It mainly looks at people with newly diagnosed, untreated sleep apnea and early high blood pressure.

Detroit, Michigan
NCT04991389Recruiting· Phase 4
Test a breathing study plan for kids with sleep apnea after surgery

This trial studies how to improve outcomes for children who still have obstructive sleep apnea after having their tonsils and adenoids removed. It uses computer modeling (based on breathing/airflow) and may include a special breathing gas during testing in some parts of the study.

Cincinnati, Ohio

Hear when a new Obstructive Sleep Apnea trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.